+34.8%
MRNA vs FBTC
+60.2%
-25.3%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FBTC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.3% | +5.1% | +5.3% |
| 7D | -1.1% | -3.1% | +2.0% | +0.2% |
| 30D | +126.1% | +22.0% | +104.1% | +110.4% |
| 3M | +190.0% | +21.6% | +168.4% | +169.9% |
| 6M | +157.2% | +9.2% | +148.0% | +145.4% |
| YTD | +388.2% | -11.8% | +400.0% | +385.2% |
| 1Y | +467.0% | -32.7% | +499.7% | +492.9% |
| All | +34.8% | +60.2% | -25.3% | +20.3% |
Cumulative growth
Daily Returns
Daily percentage return beside FBTC.
Daily Out/Under-Performance
Portfolio return minus FBTC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FBTC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FBTC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling